Hannah Lorden

Hannah Lorden is an experienced clinical trial professional currently serving as an Associate Clinical Trial Manager at Regor Therapeutics Group since August 2025. Prior to this role, Hannah was a Clinical Research Associate at Arrowhead Pharmaceuticals, where responsibilities included managing oversight of four Phase 1 clinical trials. At Bristol Myers Squibb, a pivotal position as a Clinical Trial Associate involved critical contributions to a global oncology trial that received FDA approval in November 2023. Earlier experience includes a role as a Clinical Trial Assistant at Polaris Pharmaceuticals, overseeing compliance for global oncology trials, and technical support and customer service roles at TriLink BioTechnologies. Hannah holds a Bachelor's degree in Pharmaceutical Sciences from the Massachusetts College of Pharmacy and Health Sciences.